BIOMERICA financials
$2.30−3.76%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 May 31 | Q3 '26 Feb 28 | Q2 '26 Nov 30 | Q1 '26 Aug 31 | Q4 '25 May 31 | Q3 '25 Feb 28 | Q2 '25 Nov 30 | Q1 '25 Aug 31 | Q4 '24 May 31 | Q3 '24 Feb 29 | Q2 '24 Nov 30 | Q1 '24 Aug 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $875.0K | $987.0K | $1.2M | $1.4M | $749.0K | $1.1M | $1.6M | $1.8M | $1.1M | $1.0M | $1.6M | $1.7M |
| Gross profit | -$71.0K | -$44.0K | $51.0K | $424.0K | -$244.0K | $19.0K | $437.0K | $289.0K | $20.0K | -$149.0K | $325.0K | $412.0K |
| Gross margin | −8.1% | −4.5% | 4.2% | 30.7% | −32.6% | 1.7% | 26.7% | 16.0% | 1.8% | −14.7% | 20.7% | 24.1% |
| Operating income | -$1.5M | -$1.3M | -$1.4M | -$1.1M | -$1.6M | -$1.2M | -$993.0K | -$1.4M | -$1.5M | -$2.0M | -$1.6M | -$1.2M |
| Net income | -$1.1M | -$1.3M | -$1.3M | $2.0K | -$1.5M | -$1.2M | -$950.0K | -$1.3M | -$1.4M | -$1.9M | -$1.5M | -$1.1M |
| Net margin | −130.9% | −132.9% | −109.1% | 0.1% | −206.1% | −103.9% | −58.1% | −72.8% | −127.3% | −188.6% | −96.2% | −66.1% |
| Diluted EPS | $-0.37 | $-0.44 | $-0.45 | $0.00 | $-0.61 | $-0.48 | $-0.44 | $-0.63 | $-0.68 | $-0.88 | $-0.72 | $-0.56 |
| EBITDA | -$1.5M | -$1.3M | -$1.4M | -$1.1M | -$1.5M | -$1.2M | -$971.0K | -$1.3M | -$1.5M | -$2.0M | -$1.6M | -$1.2M |
| Operating cash flow | -$912.0K | -$1.3M | -$991.0K | -$268.0K | -$662.0K | -$1.0M | -$791.0K | -$1.3M | -$1.0M | -$1.8M | -$842.0K | -$1.7M |
| Free cash flow | -$912.0K | -$1.3M | -$991.0K | -$268.0K | -$662.0K | -$1.0M | -$791.0K | -$1.3M | -$1.1M | -$1.8M | -$848.0K | -$1.7M |
| Diluted shares | 3.1M | 3.0M | 2.9M | 2.6M | 2.5M | 2.4M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M |
Balance sheet
| Period end | May 31 | Feb 28 | Nov 30 | Aug 31 | May 31 | Feb 28 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.3M | $1.3M | $2.5M | $3.1M | $2.4M | $3.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $6.8M | $4.9M | $6.0M | $6.9M | $5.9M | $7.4M |
| Total liabilities | $4.1M | $1.6M | $1.6M | $1.7M | $1.8M | $1.8M |
| Shareholders' equity | $2.6M | $3.3M | $4.4M | $5.2M | $4.1M | $5.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology